Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer.

Workel HH, Lubbers JM, Arnold R, Prins TM, van der Vlies P, de Lange K, Bosse T, van Gool IC, Eggink FA, Wouters MCA, Komdeur FL, van der Slikke EC, Creutzberg CL, Kol A, Plat A, Glaire M, Church DN, Nijman HW, de Bruyn M.

Cancer Immunol Res. 2019 May;7(5):784-796. doi: 10.1158/2326-6066.CIR-18-0517. Epub 2019 Mar 14.

PMID:
30872264
2.

Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade.

Wollinga T, Ezendam NPM, Eggink FA, Smink M, van Hamont D, Pijlman B, Boss E, Robbe EJ, Ngo H, Boll D, Mom CH, van der Aa MA, Kruitwagen RFLP, Nijman HW, Pijnenborg JMA.

Gynecol Surg. 2018;15(1):7. doi: 10.1186/s10397-018-1040-x. Epub 2018 Feb 27.

3.

The impact of centralization of services on treatment delay in ovarian cancer: A study on process quality.

Eggink FA, Vermue MC, Van der Spek C, Arts HJ, Apperloo MJ, Nijman HW, Niemeijer GC.

Int J Qual Health Care. 2017 Oct 1;29(6):810-816. doi: 10.1093/intqhc/mzx107.

PMID:
29025074
4.

Corrigendum to "Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification" [Eur J Cancer 78 (2017) 82-90].

Eggink FA, Mom CH, Bouwman K, Boll D, Becker JH, Creutzberg CL, Niemeijer GC, van Driel WJ, Reyners AK, van der Zee AG, Bremer GL, Ezendam NP, Kruitwagen RF, Pijnenborg JM, Hollema H, Nijman HW, van der Aa MA.

Eur J Cancer. 2017 Oct;84:370. doi: 10.1016/j.ejca.2017.08.003. Epub 2017 Aug 23. No abstract available.

PMID:
28844347
5.

Surgery for patients with newly diagnosed advanced ovarian cancer: which patient, when and extent?

Eggink FA, Koopmans CM, Nijman HW.

Curr Opin Oncol. 2017 Sep;29(5):351-358. doi: 10.1097/CCO.0000000000000387. Review.

PMID:
28614136
6.

Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients.

Eggink FA, Mom CH, Boll D, Ezendam NPM, Kruitwagen RFPM, Pijnenborg JMA, van der Aa MA, Nijman HW.

Gynecol Oncol. 2017 Aug;146(2):380-385. doi: 10.1016/j.ygyno.2017.05.025. Epub 2017 May 25.

PMID:
28552255
7.

Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification.

Eggink FA, Mom CH, Bouwman K, Boll D, Becker JH, Creutzberg CL, Niemeijer GC, van Driel WJ, Reyners AK, van der Zee AG, Bremer GL, Ezendam NP, Kruitwagen RF, Pijnenborg JM, Hollema H, Nijman HW, van der Aa MA.

Eur J Cancer. 2017 Jun;78:82-90. doi: 10.1016/j.ejca.2017.03.010. Epub 2017 Apr 14. Erratum in: Eur J Cancer. 2017 Oct;84:370.

PMID:
28415003
8.

Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition.

Eggink FA, Van Gool IC, Leary A, Pollock PM, Crosbie EJ, Mileshkin L, Jordanova ES, Adam J, Freeman-Mills L, Church DN, Creutzberg CL, De Bruyn M, Nijman HW, Bosse T.

Oncoimmunology. 2016 Dec 9;6(2):e1264565. doi: 10.1080/2162402X.2016.1264565. eCollection 2017.

9.

CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy.

Komdeur FL, Wouters MC, Workel HH, Tijans AM, Terwindt AL, Brunekreeft KL, Plat A, Klip HG, Eggink FA, Leffers N, Helfrich W, Samplonius DF, Bremer E, Wisman GB, Daemen T, Duiker EW, Hollema H, Nijman HW, de Bruyn M.

Oncotarget. 2016 Nov 15;7(46):75130-75144. doi: 10.18632/oncotarget.12077.

10.

Improved outcomes due to changes in organization of care for patients with ovarian cancer in the Netherlands.

Eggink FA, Mom CH, Kruitwagen RF, Reyners AK, Van Driel WJ, Massuger LF, Niemeijer GC, Van der Zee AG, Van der Aa MA, Nijman HW.

Gynecol Oncol. 2016 Jun;141(3):524-530. doi: 10.1016/j.ygyno.2016.04.012. Epub 2016 Apr 23.

PMID:
27090157
11.

CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma.

Workel HH, Komdeur FL, Wouters MC, Plat A, Klip HG, Eggink FA, Wisman GB, Arts HJ, Oonk MH, Mourits MJ, Yigit R, Versluis M, Duiker EW, Hollema H, de Bruyn M, Nijman HW.

Eur J Cancer. 2016 Jun;60:1-11. doi: 10.1016/j.ejca.2016.02.026. Epub 2016 Mar 31.

PMID:
27038842
12.

POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer.

van Gool IC, Eggink FA, Freeman-Mills L, Stelloo E, Marchi E, de Bruyn M, Palles C, Nout RA, de Kroon CD, Osse EM, Klenerman P, Creutzberg CL, Tomlinson IP, Smit VT, Nijman HW, Bosse T, Church DN.

Clin Cancer Res. 2015 Jul 15;21(14):3347-3355. doi: 10.1158/1078-0432.CCR-15-0057. Epub 2015 Apr 15.

13.

Use of anterior segment optical coherence tomography to study corneal changes after collagen cross-linking.

Doors M, Tahzib NG, Eggink FA, Berendschot TT, Webers CA, Nuijts RM.

Am J Ophthalmol. 2009 Dec;148(6):844-51.e2. doi: 10.1016/j.ajo.2009.06.031. Epub 2009 Sep 24.

PMID:
19781685
14.

Late-onset decentration of iris-fixated phakic intraocular lenses: a case series.

Doors M, Eggink FA, Webers CA, Nuijts RM.

Am J Ophthalmol. 2009 Jun;147(6):997-1003, 1003.e1-2. doi: 10.1016/j.ajo.2009.01.012. Epub 2009 Mar 27.

PMID:
19327741
15.

Higher-order aberrations after implantation of iris-fixated rigid or foldable phakic intraocular lenses.

Tahzib NG, MacRae SM, Yoon G, Berendschot TT, Eggink FA, Hendrikse F, Nuijts RM.

J Cataract Refract Surg. 2008 Nov;34(11):1913-20. doi: 10.1016/j.jcrs.2008.07.014.

PMID:
19006738
16.
17.

Recurrent intraocular inflammation after implantation of the Artiflex phakic intraocular lens for the correction of high myopia.

Tahzib NG, Eggink FA, Frederik PM, Nuijts RM.

J Cataract Refract Surg. 2006 Aug;32(8):1388-91.

PMID:
16863981
18.

Functional outcome and patient satisfaction after Artisan phakic intraocular lens implantation for the correction of myopia.

Tahzib NG, Bootsma SJ, Eggink FA, Nuijts RM.

Am J Ophthalmol. 2006 Jul;142(1):31-39.

PMID:
16815248
19.

Evaluation of pupil dynamics after implantation of artisan phakic intraocular lenses.

Bootsma SJ, Tahzib NG, Eggink FA, de Brabander J, Nuijts RM.

J Refract Surg. 2006 Apr;22(4):367-71.

PMID:
16629069
20.

Functional outcomes and patient satisfaction after laser in situ keratomileusis for correction of myopia.

Tahzib NG, Bootsma SJ, Eggink FA, Nabar VA, Nuijts RM.

J Cataract Refract Surg. 2005 Oct;31(10):1943-51.

PMID:
16338565
21.

Recovery of the visual acuity in a family with Reis-Bückler dystrophy.

Eggink FA, Geerards AJ, Beekhuis WH.

Cont Lens Anterior Eye. 2002 Jun;25(2):67-72.

PMID:
16303479
22.

Wavefront-guided versus standard laser in situ keratomileusis to correct low to moderate myopia.

Nuijts RM, Nabar VA, Hament WJ, Eggink FA.

J Cataract Refract Surg. 2002 Nov;28(11):1907-13.

PMID:
12457662
23.

Postoperative management and follow-up after corneal flap loss following laser in situ keratomileusis.

Eggink FA, Eggink CA, Beekhuis WH.

J Cataract Refract Surg. 2002 Jan;28(1):175-9.

PMID:
11777726
24.

Contact lens fitting in a patient with keratectasia after laser in situ keratomileusis.

Eggink FA, Beekhuis WH.

J Cataract Refract Surg. 2001 Jul;27(7):1119-23.

PMID:
11489586
25.

Rigid gas-permeable contact lens fitting in LASIK patients for the correction of multifocal corneas.

Eggink FA, Beekhuis WH, Nuijts RM.

Graefes Arch Clin Exp Ophthalmol. 2001 Jun;239(5):361-6.

PMID:
11482340
26.
27.

Topography following keratoplasty in cats is not representative of that in humans.

Eggink FA, Melles GR, Rietveld FJ, Beekhuis WH, Binder PS.

J Refract Surg. 1999 Jan-Feb;15(1):74-5. No abstract available.

PMID:
9987730
28.

A surgical technique for posterior lamellar keratoplasty.

Melles GR, Eggink FA, Lander F, Pels E, Rietveld FJ, Beekhuis WH, Binder PS.

Cornea. 1998 Nov;17(6):618-26.

PMID:
9820943
29.

Enlargement of the photorefractive keratectomy optical zone.

Eggink FA, Beekhuis WH, Trokel SL, den Boon JM.

J Cataract Refract Surg. 1996 Nov;22(9):1159-64.

PMID:
8972366
30.
31.

Contact lenses following keratoplasty.

Beekhuis WH, van Rij G, Eggink FA, Vreugdenhil W, Schoevaart CE.

CLAO J. 1991 Jan;17(1):27-9.

PMID:
2007281
32.

Changes in corneal thickness under four different rigid gas permeable contact lenses for daily wear.

Vreugdenhil W, Eggink FA, Beekhuis WH, Theeuwes A.

Optom Vis Sci. 1990 Sep;67(9):670-2.

PMID:
2234824
33.

Adrenal cyst complicated by massive haemorrhage.

Eggink FA, Rijnders WP, Sonneveldt HA.

Arch Chir Neerl. 1965;17(3):165-8. No abstract available.

PMID:
5883528
34.

PANCREATIC INJURIES.

EGGINK FA.

Arch Chir Neerl. 1964;16:43-54. No abstract available.

PMID:
14242118
35.

[Traumatic chylothorax].

EGGINK FA.

Ned Tijdschr Geneeskd. 1961 Nov 18;105:2231-4. Dutch. No abstract available.

PMID:
13889441
36.

[Experiences with peripheral vascular surgery].

EGGINK FA.

Ned Tijdschr Geneeskd. 1957 Nov 23;101(47):2250-2. Dutch. No abstract available.

PMID:
13504296
37.

[The floating kidney].

EGGINK FA.

Geneeskd Gids. 1957 Feb 14;35(4):53-9. Dutch. No abstract available.

PMID:
13415342
38.

Wandering kidney.

EGGINK FA.

Arch Chir Neerl. 1957;9(2):99-108. No abstract available.

PMID:
13459740
39.

[Arteriography of pelvis and legs].

BLICKMAN JR, EGGINK FA.

Ned Tijdschr Geneeskd. 1956 Dec 29;100(52):3869-73. Dutch. No abstract available.

PMID:
13400200
40.

[Abdominal tumor of unusual dimension].

EGGINK FA.

Ned Tijdschr Geneeskd. 1956 Dec 22;100(51):3853-5. Dutch. No abstract available.

PMID:
13400196
41.

[Nephropexy].

EGGINK FA.

Ned Tijdschr Geneeskd. 1956 Oct 20;100(42):3050-2. Dutch. No abstract available.

PMID:
13387846
42.

[Treatment of central hip dislocation].

EGGINK FA.

Ned Tijdschr Geneeskd. 1955 Nov 12;99(46):3424-32. Dutch. No abstract available.

PMID:
13288626
43.

[Three patients with congenital vascular anomalies].

EGGINK FA.

Ned Tijdschr Geneeskd. 1953 Mar 14;97(11):671-6. Undetermined Language. No abstract available.

PMID:
13063625

Supplemental Content

Loading ...
Support Center